0.28
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché FGEN Giù?
Forum
Previsione
Fibrogen Inc Borsa (FGEN) Ultime notizie
FibroGen to Participate in the 24th Annual Needham Virtual Healthcare Conference - GlobeNewswire
FibroGen extends merger option deadline with Fortis - Investing.com Australia
FibroGen extends merger option deadline with Fortis By Investing.com - Investing.com South Africa
Morgan Stanley’s Adam Jonas Is Pounding the Table on This 1 ‘Unique’ Stock - The Globe and Mail
FibroGen reports promising FG-3246 study results for prostate cancer - Investing.com
FibroGen Announces Publication of Results from Phase 1 - GlobeNewswire
1 Top Cryptocurrency to Buy Before It Soars 14,623%, According to Michael Saylor - The Globe and Mail
Fibrogen CEO Wettig Thane buys $50,663 in common stock By Investing.com - Investing.com Australia
Fibrogen CEO Wettig Thane buys $50,663 in common stock - Investing.com India
Fibrogen director James Schoeneck buys $105,040 in stock By Investing.com - Investing.com Canada
In the Red? AstraZeneca Acquires FibroGen, Inc.’s China Subsidiary - Law Street Media
FibroGen, Inc. (NASDAQ:FGEN) Q4 2024 Earnings Call Transcript - Insider Monkey
FibroGen Full Year 2024 Earnings: Beats Expectations - Yahoo
FibroGen Inc (FGEN) Q4 2024 Earnings Call Highlights: Navigating Revenue Declines with ... - Yahoo Finance
FibroGen Reports Fourth Quarter and Full Year 2024 Financial Results - The Manila Times
FibroGen Inc (FGEN) Q4 2024 Earnings Call Highlights: Navigating Revenue Declines with ... By GuruFocus - Investing.com Canada
FibroGen Inc (FGEN) Q4 2024 Earnings Call Highlights: Navigating Revenue Declines with Strategic Initiatives - GuruFocus.com
FibroGen Announces Strategic Sale and Financial Outlook - TipRanks
FibroGen: Q4 Earnings Snapshot - mySA
Earnings call transcript: FibroGen reports Q4 2024 EPS beat, stock dips - Investing.com Canada
Earnings call transcript: FibroGen reports Q4 2024 EPS beat, stock dips By Investing.com - Investing.com South Africa
FibroGen Inc earnings beat by $0.35, revenue fell short of estimates - Investing.com Canada
FibroGen Inc reports results for the quarter ended December 31Earnings Summary - TradingView
FibroGen Inc Reports Q4 2024 Earnings: EPS Loss of $0.08 Beats E - GuruFocus
FIBROGEN Earnings Results: $FGEN Reports Quarterly Earnings - Nasdaq
FIBROGEN INC SEC 10-K Report - TradingView
FibroGen, Inc. Announces Sale of FibroGen China to AstraZeneca for $160 Million and Updates on Clinical Trials - Nasdaq
FibroGen's Strategic $160M China Exit Extends Cash Runway to 2027 Amid Latest Earnings - StockTitan
FIBROGEN Earnings Preview: Recent $FGEN Insider Trading, Hedge Fund Activity, and More - Nasdaq
StockNews.com Initiates Coverage on FibroGen (NASDAQ:FGEN) - Defense World
Weekly CEO Buys Highlight: Camping World, FibroGen - GuruFocus.com
AstraZeneca’s $160 Million Acquisition of FibroGen China - Global Legal Chronicle
Ropes & Gray Advises FibroGen in $160 Million Sale of Fibrogen China to AstraZeneca - Ropes & Gray LLP
FibroGen to Report Fourth Quarter and Full Year 2024 Financial Results - The Manila Times
FibroGen, Inc. to Announce Q4 and Full Year 2024 Financial Results on March 17 - Nasdaq
When Will FibroGen Reveal Its 2024 Performance? Key Date for Investors Announced - StockTitan
FibroGen, Inc. to Host Earnings Call - ACCESS Newswire
FibroGen announces $30M "at the market" equity offering - Investing.com India
FibroGen announces $30M "at the market" equity offering By Investing.com - Investing.com South Africa
FibroGen Says Entered ATM Equity Offering Sales Agreement Relating To Sale From Time To Time Of Shares Of Common Stock - Marketscreener.com
Form 424B5 FIBROGEN INC - StreetInsider.com
Asia Deal Watch: AstraZeneca Buys FibroGen’s Chinese Subsidiary - insights.citeline.com
FibroGen Inc Announces Sale of China Subsidiary to AstraZeneca f - GuruFocus.com
Investor Network: FibroGen, Inc. to Host Earnings Call - ACCESS Newswire
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):